Keep up-to-date with the latest access to medicines news and research, plus interviews and opinion from our partners and other experts, and videos and photo stories of our work.
News - Page 14 of 29
-
Russian NGOs oppose Gilead’s patent for HIV drug, Truvada
Humanitarian Action with technical support from ITPCru has opposed Gilead’s patent in Russia for the combination of two antiretroviral drugs,...
-
Danylo: Positive attitudes start with teaching – and effective HIV treatment
Danylo (name changed), 18, shares information about HIV with his university friends in Cherkassy, Ukraine. For example, “that HIV is...
-
Letter to ViiV Healthcare: No more time to waste – increase access to dolutegravir in Eastern Europe and Central Asia
Dolutegravir is an essential drug in HIV treatment, recommended by the World Health Organization (WHO). Despite the drug being approved...
-
Vera: HIV targets won’t be met without gender equality and accessible treatment
On the day that new research is published, showing that countries are being overcharged by $34 billion a year for HIV drugs, Vera Varyga,...
-
New data: Treat HIV for just four weeks of global pharmaceutical sales
The Make Medicines Affordable campaign is calling for a widespread switch from patented to generic HIV drugs so that at...
-
AIDS 2020 leadership workshop: Strategies for lowering drug prices
Activists, policy-makers, researchers and healthcare providers joined a leadership workshop led by ITPC’s Make Medicines Affordable campaign at AIDS 2020...
-
COVID-19: Another of Gilead’s FIVE patent applications on remdesivir is opposed in Argentina
Our campaign partner, Fundación GEP, has filed a second patent opposition against one of Gilead’s numerous patent applications for the...
-
AIDS 2020 exhibition: Love, life and riots
We’re exhibiting at #AIDS2020Virtual, the world’s largest virtual AIDS conference. Our photo exhibition Love, Life and Riots will be on...
-
What’s on: AIDS 2020 Virtual for treatment activists
Kicking off on Monday 6 July, with a workshop on innovative strategies to reduce prohibitive drug prices, we’ve compiled some...
-
Ukraine: 100% LIFE opposes patent on TB drug for children
Our campaign partner in Ukraine, 100% LIFE, has submitted the first patent opposition on bedaquiline in the Eastern Europe and Central...
-
“Women must be able to decide what they want – for themselves”
Yupa, 46, from Lamphun, Thailand, is advocating for women to have more choices and control over their own sexual and...
-
Argentina: Fundación GEP opposes Gilead’s patent application on remdesivir
Our partner, Fundación GEP, has filed a patent opposition against Gilead’s patent application on remdesivir before the Argentinean Patent Office....